JP2024534348A5 - - Google Patents
Info
- Publication number
- JP2024534348A5 JP2024534348A5 JP2024515564A JP2024515564A JP2024534348A5 JP 2024534348 A5 JP2024534348 A5 JP 2024534348A5 JP 2024515564 A JP2024515564 A JP 2024515564A JP 2024515564 A JP2024515564 A JP 2024515564A JP 2024534348 A5 JP2024534348 A5 JP 2024534348A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- sequence number
- includes sequence
- sequence includes
- tau
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025115822A JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163242437P | 2021-09-09 | 2021-09-09 | |
| US63/242,437 | 2021-09-09 | ||
| PCT/US2022/042963 WO2023039107A2 (en) | 2021-09-09 | 2022-09-08 | Phospho-tau antibodies and methods of use |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115822A Division JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Division JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534348A JP2024534348A (ja) | 2024-09-20 |
| JP2024534348A5 true JP2024534348A5 (https=) | 2025-07-17 |
| JP7836885B2 JP7836885B2 (ja) | 2026-03-27 |
Family
ID=85507770
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515564A Active JP7836885B2 (ja) | 2021-09-09 | 2022-09-08 | ホスホ－タウ抗体および使用の方法 |
| JP2025115822A Active JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Pending JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115822A Active JP7828500B2 (ja) | 2021-09-09 | 2025-07-09 | ホスホ－タウ抗体および使用の方法 |
| JP2025239499A Pending JP2026034506A (ja) | 2021-09-09 | 2025-12-08 | ホスホ－タウ抗体および使用の方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US12276671B2 (https=) |
| EP (1) | EP4399524A4 (https=) |
| JP (3) | JP7836885B2 (https=) |
| KR (1) | KR102888596B1 (https=) |
| CN (1) | CN118235043A (https=) |
| CA (1) | CA3231228A1 (https=) |
| WO (1) | WO2023039107A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023039107A2 (en) | 2021-09-09 | 2023-03-16 | Alzpath, Inc. | Phospho-tau antibodies and methods of use |
| KR20250173598A (ko) * | 2023-03-16 | 2025-12-10 | 알즈패스, 인크. | 신경퇴행성 질환의 진단 및 치료 방법 |
| CN119470917A (zh) * | 2024-11-14 | 2025-02-18 | 苏州智研医康医疗科技有限公司 | 一种检测人血中阿尔茨海默病相关蛋白的试剂盒及检测方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4694778A (en) | 1984-05-04 | 1987-09-22 | Anicon, Inc. | Chemical vapor deposition wafer boat |
| US20040219509A1 (en) | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| US7604956B2 (en) | 2004-03-01 | 2009-10-20 | Biotraces, Inc. | Supersensitive immunoassays |
| ES2367311T3 (es) | 2004-04-15 | 2011-11-02 | University Of Florida Research Foundation, Inc. | Productos de degradación proteolítica de map-2 como biomarcadores de diagnóstico para las lesiones neurales. |
| US7914734B2 (en) | 2007-12-19 | 2011-03-29 | Singulex, Inc. | Scanning analyzer for single molecule detection and methods of use |
| US20110177509A1 (en) | 2008-07-23 | 2011-07-21 | The Washington University | Risk factors and a therapeutic target for neurodegenerative disorders |
| WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
| JP2013518927A (ja) * | 2010-02-09 | 2013-05-23 | ブリストル−マイヤーズ スクイブ カンパニー | 免疫アッセイ標準物質およびアッセイ内の校正標準物質を用いる臨床バイオマーカーの測定 |
| WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
| WO2012142300A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event |
| GB201112056D0 (en) | 2011-07-14 | 2011-08-31 | Univ Leuven Kath | Antibodies |
| KR101981351B1 (ko) | 2011-10-07 | 2019-09-02 | 에이씨 이뮨 에스.에이. | 타우를 인식하는 포스포특이적 항체 |
| MX350311B (es) | 2011-12-20 | 2017-09-01 | Janssen Biotech Inc | Anticuerpos anti-phf-tau y sus usos. |
| NZ630542A (en) * | 2012-08-16 | 2017-06-30 | Ipierian Inc | Methods of treating a tauopathy |
| AR100978A1 (es) * | 2014-06-26 | 2016-11-16 | Hoffmann La Roche | LANZADERAS CEREBRALES DE ANTICUERPO HUMANIZADO ANTI-Tau(pS422) Y USOS DE LAS MISMAS |
| NZ775762A (en) * | 2015-06-05 | 2025-02-28 | Genentech Inc | Anti-tau antibodies and methods of use |
| GB201518675D0 (en) * | 2015-10-21 | 2015-12-02 | Cellcap Technologies Ltd | Detection of structural forms of proteins |
| US20180080945A1 (en) * | 2016-09-20 | 2018-03-22 | Nanosomix, Inc. | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders |
| KR102048987B1 (ko) * | 2017-02-22 | 2019-11-27 | 한국과학기술연구원 | 신경퇴행성 장애의 진단을 위한 정보 제공 방법 |
| JP7029718B2 (ja) * | 2017-07-31 | 2022-03-04 | 国立研究開発法人量子科学技術研究開発機構 | リン酸化タウタンパク質の測定方法 |
| WO2019085804A1 (en) | 2017-11-02 | 2019-05-09 | Peking University | Methods and use for detecting and inhibiting cell-free mg53 |
| EP3706795A4 (en) | 2017-11-09 | 2021-10-13 | Pinteon Therapeutics Inc. | METHODS AND COMPOSITIONS FOR GENERATING AND USING HUMANIZED CONFORMATION SPECIFIC PHOSPHORYLATED TAU ANTIBODIES |
| US20200377609A1 (en) | 2018-02-14 | 2020-12-03 | Kite Pharma, Inc. | Anti-idiotypic antibodies directed to the antigen-binding portion of an bcma-binding molecule |
| WO2020105700A1 (ja) | 2018-11-22 | 2020-05-28 | 富士レビオ株式会社 | 抗体コンジュゲート |
| KR102905634B1 (ko) | 2019-05-31 | 2025-12-30 | 일라이 릴리 앤드 캄파니 | 인간 타우를 표적화하는 화합물 및 방법 |
| WO2021178545A1 (en) | 2020-03-03 | 2021-09-10 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Proteomic screening for diseases |
| CN112505322A (zh) * | 2020-10-16 | 2021-03-16 | 威海纽普生物技术有限公司 | 阿尔茨海默病标志物p-Tau217检测试剂盒及其制造方法 |
| US20240003918A1 (en) | 2020-11-30 | 2024-01-04 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
| TWI843040B (zh) | 2021-01-11 | 2024-05-21 | 美商美國禮來大藥廠 | 抗N3pGlu類澱粉β抗體及其用途 |
| WO2023039107A2 (en) | 2021-09-09 | 2023-03-16 | Alzpath, Inc. | Phospho-tau antibodies and methods of use |
| KR20250173598A (ko) * | 2023-03-16 | 2025-12-10 | 알즈패스, 인크. | 신경퇴행성 질환의 진단 및 치료 방법 |
-
2022
- 2022-09-08 WO PCT/US2022/042963 patent/WO2023039107A2/en not_active Ceased
- 2022-09-08 CN CN202280074834.XA patent/CN118235043A/zh active Pending
- 2022-09-08 CA CA3231228A patent/CA3231228A1/en active Pending
- 2022-09-08 KR KR1020257022547A patent/KR102888596B1/ko active Active
- 2022-09-08 EP EP22868084.9A patent/EP4399524A4/en active Pending
- 2022-09-08 JP JP2024515564A patent/JP7836885B2/ja active Active
-
2024
- 2024-03-08 US US18/599,751 patent/US12276671B2/en active Active
- 2024-07-11 US US18/770,102 patent/US12339290B2/en active Active
-
2025
- 2025-05-16 US US19/210,582 patent/US20250277799A1/en active Pending
- 2025-07-09 JP JP2025115822A patent/JP7828500B2/ja active Active
- 2025-12-08 JP JP2025239499A patent/JP2026034506A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024534348A5 (https=) | ||
| CN114751981B (zh) | 抗SARS-CoV-2核衣壳蛋白的单克隆抗体及其应用 | |
| JP2016505634A5 (https=) | ||
| CN116082498A (zh) | 一种猴痘病毒蛋白的单克隆抗体及其应用 | |
| JP2015527365A5 (https=) | ||
| JP2015531768A5 (https=) | ||
| JP2015502752A5 (https=) | ||
| JP2019504013A5 (https=) | ||
| JP2019504014A5 (https=) | ||
| JP2014518624A5 (https=) | ||
| KR101192130B1 (ko) | 비브리오균의 외막단백질에 대한 항체 및 이를 이용한 상기 균의 검출 방법 | |
| JP5821198B2 (ja) | 抗ｉｌ２８ｂ抗体及びこれを用いたｉｌ２８ｂの測定方法 | |
| CN116284368A (zh) | 抗人MxA抗体或其抗原结合部分 | |
| CN106939034A (zh) | 用于鉴定受试者所感染的hev基因型的方法和试剂盒 | |
| KR102709435B1 (ko) | SARS-CoV-2 특이적 신규 항체를 이용한 SARS-CoV-2의 검출방법 | |
| JPWO2024070874A5 (https=) | ||
| CN118440188A (zh) | 抗新型冠状病毒或其n蛋白抗体、检测新型冠状病毒或其n蛋白的试剂和试剂盒 | |
| CN116120440A (zh) | 抗SARS-CoV-2刺突蛋白S1的单克隆抗体及其应用 | |
| JP2024544885A5 (https=) | ||
| CN116514989B (zh) | 全能核酸酶抗体及其应用 | |
| EP3177312B1 (en) | Method and kit for detecting bacterial infection | |
| JP2018027024A (ja) | アプタマー及び抗体検出方法 | |
| KR102798975B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| KR102798983B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| EP3857225B1 (en) | Complex stabilizing components and detection methods thereof |